Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
Top Cited Papers
- 1 November 2003
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 362 (9395), 1517-1526
- https://doi.org/10.1016/s0140-6736(03)14738-1
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Cannabis and the brainBrain, 2003
- The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosisMultiple Sclerosis Journal, 1999
- The Perceived Effects of Smoked Cannabis on Patients with Multiple SclerosisEuropean Neurology, 1997
- Inter-rater reliability of the Ashworth scale in multiple sclerosisClinical Rehabilitation, 1994
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- The Rivermead Mobility Index: A further development of the Rivermead Motor AssessmentInternational Disability Studies, 1991
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- Treatment of Human Spasticity with Δ9‐TetrahydrocannabinolThe Journal of Clinical Pharmacology, 1981